{"id":"NCT00573183","sponsor":"University of Washington","briefTitle":"Stimulant Abuser Groups to Engage in 12-Step","officialTitle":"Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2007-12-14","resultsPosted":"2014-01-29","lastUpdate":"2016-12-05"},"enrollment":471,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Drug Abuse"],"interventions":[{"type":"BEHAVIORAL","name":"STAGE-12","otherNames":[]},{"type":"BEHAVIORAL","name":"Treatment as Usual","otherNames":[]}],"arms":[{"label":"STAGE-12","type":"EXPERIMENTAL"},{"label":"Treatment as Usual","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.","primaryOutcome":{"measure":"Days of Stimulant Use","timeFrame":"6 months","effectByArm":[{"arm":"Treatment as Usual","deltaMin":2.35,"sd":5.39},{"arm":"STAGE-12","deltaMin":2.13,"sd":4.32}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"},{"comp":"OG000 vs OG001","p":"<0.01"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["22657748"],"seeAlso":["http://www.drugabuse.gov/about-nida/organization/cctn/ctn/research-studies/stimulant-abuser-groups-to-engage-in-12-step-stage-12-evaluation-combined-i"]},"adverseEventsSummary":{"seriousAny":{"events":29,"n":234},"commonTop":["depression","suicidal ideation","back pain","pneumonia","nasopharyngitis"]}}